The Big Pharma industry is the biggest financial sponsor of government healthcare programs, according to the National Institutes of Health.
In the past decade alone, it has spent more than $9.5 billion on public healthcare, more than any other industry.
And this is despite the fact that there are many reasons why healthcare costs are higher than they were in 2000 and 2009, when Big Pharma was at its peak.
For example, the Affordable Care Act, which is the main driver of the massive growth of health insurance companies in recent years, has made it far more difficult for employers to fire workers without giving them a severance package or severance payments, and it has made the work environment at the heart of medicine even more hostile to workers.
In a country with such a huge health-care infrastructure, a growing body of research suggests that the Big Business-supported government healthcare system is not doing enough to address the growing burden of chronic disease and prevent the deaths of people.
The National Academies of Sciences, Engineering, and Medicine released its report, The Big Business in Health Care, in late May.
It looked at the ways that Big Pharma has spent over $100 billion since 2000 to pay for government-funded health care and to provide healthcare for its corporate executives, including the CEOs of pharmaceutical companies, as well as employees who work for them.
The report found that Big Business has spent an astonishing $1.8 trillion on healthcare since 2000.
The study also found that the pharmaceutical industry spent more money per employee in 2020 than all the other industries combined.
And it found that healthcare spending by Big Pharma companies was a huge factor in the massive rise in the health-policy deficit that was the subject of the Congressional Budget Office report, which warned that healthcare costs would continue to rise as the country transitions to a more competitive marketplace.
Big Pharma’s healthcare spending has grown substantially in the past few decades, as the industry has expanded its marketing of drugs for chronic disease, according a report released earlier this month by the National Bureau of Economic Research.
That means Big Pharma is able to pay its executives handsomely for providing healthcare to its employees, and the companies have done so by selling expensive and powerful drugs to the public.
This has been a lucrative business for Big Pharma.
In 2015, Big Pharma spent nearly $300 billion to pay the CEOs and top executives of its pharmaceutical companies for health care services, according the report.
According to the report, Big Pharmaceutical spent $4.9 billion on healthcare and other healthcare-related expenses for its employees in 2020.
Big pharmaceutical executives have long been paid a huge salary and benefits package for their services, as evidenced by a report from the American Enterprise Institute that shows that the top 10 CEOs of the industry made $2.2 million in total compensation in 2016.
But the Big Pharmaceutical CEOs are only a small part of the story.
According the study, the biggest beneficiaries of Big Pharma are the CEOs who work in the industry’s health-services division, which includes companies like Merck, Pfizer, and Bristol-Myers Squibb.
The company’s health care operations account for just over two-thirds of the company’s total healthcare-care expenditures.
In 2018, the health care division accounted for $3.4 billion of the overall healthcare-payments bill.
This was about 20% of all the healthcare-service-related spending.
This is a fraction of the $19.4 trillion in healthcare spending the country spent in 2020, the study found.
It was the largest single healthcare-revenue source of spending in the country.
In 2020, health care was the third-largest industry-wide source of revenue for Big Pharmaceuticals.
According, the Big Pharma industry spent nearly three times as much money per person in 2020 as the health sector itself, and more than 10 times as many people as all the industries combined, the report found.
In other words, Big Pharmaceutical spends more money on healthcare than the economy of the United States, which had the fourth-highest healthcare-income gap between its wealthy and middle class in the nation.
Big Pharms health care spending is even more staggering when compared to the health spending of the general population.
The health-related healthcare spending of people is a tiny fraction of healthcare spending overall.
The United States spends more than the entire world spends on health care, the United Nations reports.
The average American consumes about two-tenths of a cent of their annual income on healthcare, according one estimate.
In 2017, the average American spent $15,800 per year on healthcare.
In comparison, the World Health Organization estimates that the average person spends $21,000 on healthcare per year.
But Big Pharma spends far more than everyone else on healthcare in the United Kingdom, the second-highest spenders in the world.
The NHS spent about $1,700 per person per year, according an analysis from the